The new group was instigated by ten international experts who met at the Novartis Foundation in London last month to discuss recent evidence that a common viral infection may be triggering the disease and the possibility of developing a vaccine to protect individuals at risk.
“This area of diabetes research has been neglected for far too long,” says Professor Keith Taylor, of the Centre for Diabetes and Metaboloic Medicine at Barts and The London. “It is essential to follow up today’s very promising lines of research if we hope to cut the increasing burden of this disease in childhood.” These thoughts were echoed by other meeting participants, including Professor Abner Notkins of the National Institutes of Health, Washington, USA.
Type1 diabetes currently affects several million children worldwide and its incidence is rising steadily. The VIDIS Group aims to foster collaboration between research workers and look for common ways forward. “If a virus is involved, then vaccination as a preventive measure is a realistic possibility,” adds Professor Taylor.
The nature of the triggering agent in children with diabetes has long been debated. Studies in the 1960s first suggested that, the start of the disease was often associated with the coxsackie virus, a common childhood infection.
Recent epidemiological studies from Finnish scientists suggest that diabetic children are infected with these viruses long before the disease is diagnosed. And researchers in Scotland, Italy and Finland have detected coxsackie viruses in the pancreas of diabetic children at post mortem, confirming an early report.
It is now over 80 years since insulin was discovered. Although it has made the lives of people with type I diabetes possible, insulin cannot prevent its disabling complications. “We need to know what destroys the insulin-producing cells in the first place. This is why those of us gathered in London felt that our work on viruses should be extended – with urgency,” says Professor Taylor.
Professor Keith Taylor | alfa
Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku
Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy